BioSpace News Archive

Biotech Bay

Amaranth Presented MAGNITUDE (98 micron) Nine-Month Follow-up Clinical Results and Introduced DEFIANCE (85 micron) BRS Development Plan at TCT

Amaranth Medical provided an update on the company’s sirolimus-eluting bioresorbable scaffold (BRS) products at the annual Transcatheter Cardiovascular Therapeutics (TCT) meeting during the following sessions

September 28, 2018
·
4 min read
Job Trends

Myriad Announces Publication of Variant Reclassification Study in the Journal of the American Medical Association

Myriad Genetics, Inc. today announced that results from a landmark study of variant classifications following hereditary cancer genetic testing were published in the Journal of the American Medical Association (JAMA).

September 28, 2018
·
7 min read
FDA

Pfizer Snags FDA Approval for New Lung Cancer Drug Vizimpro

The U.S. Food and Drug Administration approved Pfizer’s once-per-day oral medication Vizimpro, a first-line treatment for patients with a rare form of lung cancer, the company announced late Thursday.

September 28, 2018
·
2 min read
·
Alex Keown
FDA

FDA Approves Eli Lilly’s Migraine Drug, Which Faces Stiff Market Competition

The U.S. Food and Drug Administration (FDA) approved Eli Lilly and Company’s Emgality (galcanezumab-gnlm) for migraine prevention.

September 28, 2018
·
2 min read
·
Mark Terry
BioCapital

SCRS Announces Global Summit Site Tank Finalists

Today the Society for Clinical Research Sites (SCRS) announced the finalists for the 2018 Site Tank.

September 28, 2018
·
1 min read
BioMidwest

Destaco Introduces Tolerance Compensation Clamp Series

Innovative clamping solution streamlines demanding welding and assembly applications in the automotive, aircraft and consumer goods industries

September 28, 2018
·
3 min read
Deals

Roche Focuses on T Regulatory Cells in $758 Million Acquisition of Tusk Therapeutics

Swiss-based Roche announced it is buying UK-based Tusk Therapeutics in a deal that could hit $758 million (U.S.).

September 28, 2018
·
3 min read
·
Mark Terry
Drug Development

Aimmune and DBV Eye the Finish Line for Peanut Allergy Treatments

An estimated 15 million people in the United States have allergies to more than 170 different foods, according to the non-profit Food Allergy Research and Education. New health data suggests the frequency of food allergies in children under 18 has risen 70 percent since 1997, CNBC reported.

September 28, 2018
·
2 min read
·
Alex Keown
Genetown

KSQ Gains $80 Million Series C Financing for CRISPRomics Development

Just this morning, KSQ Therapeutics disclosed that they’ve obtained an $80 million Series C financing that will be put towards the development of oncology drug candidates via CRISPRomics™, a drug discovery engine that creates insights specific to individual human genes on an industrial scale.

September 28, 2018
·
3 min read
·
Elizabeth Glasure
Business

Viracta Announces Scientific Advisory Board

Viracta Therapeutics, Inc. announced the formation of its inaugural Scientific Advisory Board.

September 28, 2018
·
3 min read